The global sterilization equipment market was estimated at USD 8.45 billion in 2024 and is projected to grow at a CAGR of 10.8% from 2025 to 2030. The primary driver of this market is the increasing incidence of healthcare-acquired infections (HAIs). According to the World Health Organization (WHO), approximately 1 in 10 patients experiences a healthcare-associated infection, with rates significantly higher in low- and middle-income countries, particularly in high-risk areas such as intensive care units (ICUs). A 2023 study by Balasubramanian et al. estimated that 136 million cases of healthcare-associated antibiotic-resistant infections occur globally every year. Moreover, this study revealed that in acute-care hospitals, 7 out of every 100 patients in high-income countries and 15 out of every 100 patients in low- and middle-income countries are likely to acquire at least one HAI during their hospital stay.
Sterilization equipment plays a crucial role in preventing the spread of infections and diseases by cleaning and sterilizing medical instruments. The growing prevalence of chronic diseases, including diabetes, cancer, and autoimmune diseases, is further expected to drive demand for sterilization equipment. Factors such as antimicrobial resistance, unhealthy lifestyles, and increased alcohol consumption also contribute to the rising burden of chronic conditions, indirectly driving the need for effective sterilization solutions.
Gather more insights about the market drivers, restrains and growth of the Sterilization Equipment Market
Regional Insights
North America:
North America is set to dominate the sterilization equipment market, with a projected share of 35.43% in 2024. The increasing prevalence of chronic diseases, such as cancer, heart disease, and diabetes, is leading to a higher hospital admission rate, particularly in the U.S. A report by the National Association of Chronic Diseases Directors in 2022 found that 60% of adult Americans have at least one chronic disease. Additionally, a growing geriatric population, along with rising life expectancy, is increasing the number of surgeries performed, which is expected to further drive the demand for sterilization equipment.
US:
The U.S. sterilization equipment market holds a significant share in 2024. Factors driving this market include the rising incidence of healthcare-acquired infections and the growing burden of chronic diseases. A CDC report from December 2022 revealed that 6 in 10 adults in the U.S. have a chronic disease, and 4 in 10 have two or more. Moreover, according to a study by Cleveland Clinic in 2021, 1 in 25 patients in the U.S. contracts an HAI daily. Companies like STERIS, ASP (Fortive Corporation), 3M, and Stryker lead the U.S. market by offering advanced sterilization products and competing on factors like innovation, product quality, and pricing.
Canada:
The Canadian market for sterilization equipment is projected to grow due to the rising number of surgeries. In 2021, 383,717 surgeries were performed in Canada, according to the OECD. The Public Health Agency of Canada reported in August 2022 that 7.9% of patients in Canadian hospitals had at least one HAI, further boosting the demand for sterilization equipment. The increasing incidence of HAIs combined with the growth in surgical procedures is expected to drive the market in Canada.
Europe:
Europe's sterilization equipment market is expected to grow significantly, driven by the rising number of surgeries and the increasing incidence of HAIs. The European Centre for Disease Control (ECDC) estimated in May 2023 that 3.1 to 4.6 million people in Europe acquire HAIs annually. Advancements in sterilization technologies, such as low-temperature sterilization methods and automation, are expected to increase adoption and further accelerate market growth in the region.
UK:
The UK sterilization equipment market is projected to grow due to the increasing prevalence of chronic diseases and the rise in HAIs. National Institute for Health and Care Excellence (NICE) data from January 2021 revealed that 300,000 patients in the UK suffer from HAIs each year. Additionally, chronic diseases like cardiovascular disease, Alzheimer’s disease, and stroke are on the rise, which leads to a growing number of surgeries and indirectly boosts demand for sterilization equipment.
Germany:
The sterilization equipment market in Germany is expected to experience moderate growth due to the rising number of hospitals and surgical procedures. Expatica reported that Germany has approximately 2,000 hospitals, with many requiring sterilization equipment to ensure the hygiene of medical devices during surgeries and admissions. The growing healthcare infrastructure and rising surgical procedures will continue to drive the market in Germany.
Asia Pacific:
The Asia Pacific (APAC) sterilization equipment market is predominantly driven by China and Japan. Factors such as the local presence of major market players, the growing incidence of HAIs and chronic diseases, and increasing awareness about new sterilization technologies are expected to propel market growth. For example, according to the Australian Bureau of Statistics, 46.6% (11.6 million) of Australians had at least one chronic condition in 2022, further driving the demand for sterilization equipment.
China:
China’s sterilization equipment market is poised for growth driven by increasing healthcare spending and rising safety concerns in the healthcare industry. A report by The State Council of China revealed that healthcare expenditure increased by 15.2% in 2020. Furthermore, as the geriatric population grows (estimated to reach 402 million by 2040), the demand for sterilization equipment is expected to rise significantly.
Latin America:
The sterilization equipment market in Latin America is expanding due to the increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases. As these conditions often lead to hospitalizations and surgeries, there is a corresponding rise in the demand for sterilization equipment. Increased healthcare spending and the growing healthcare infrastructure are expected to further support market growth.
Middle East and Africa (MEA):
The MEA sterilization equipment market is witnessing growth driven by increasing healthcare expenditure and growing awareness about sterilization practices. Governments in the region are investing more in healthcare, leading to the entry of major market players and further stimulating market growth. As the prevalence of chronic diseases rises, the need for sterilization equipment is expected to increase.
Saudi Arabia:
The Saudi Arabia sterilization equipment market is primarily driven by rising healthcare expenditures and the increasing prevalence of chronic diseases, including diabetes and heart disease. According to FIND, a nonprofit organization, these conditions are among the top causes of death in the region, leading to a greater demand for sterilization equipment in medical settings.
Browse through Grand View Research's Category Medical Devices Industry Research Reports.
- The global continuous positive airway pressure devices market size was estimated at USD 1.90 billion in 2024 and is expected to grow at a CAGR of 5.45% from 2025 to 2030.
- The global pediatric clinical trials marketsize was estimated at USD 19.9 billion in 2024 and is projected to grow at a CAGR of 5.25% from 2025 to 2030.
Key Sterilization Equipment Companies:
The following are the leading companies in the sterilization equipment market. These companies collectively hold the largest market share and dictate industry trends.
- ASP (Fortive Corporation)
- Getinge
- STERIS
- Steelco S.p.A.
- Shinva Medical Instrument Co., Ltd.
- MATACHANA
- 3M
- MMM Group
- Stryker
- Andersen Sterilizers
- HUMAN MEDITEK CO., LTD.
- SOLSTEO
- Scitek Global Co., Ltd.
- Renosem
- Labtron Equipment Ltd
- Labotronics Scientific
- Genist Technocracy Pvt. Ltd.
- DE LAMA S.P.A.
- Bionics Scientific (a Unit of Kartal Projects Pvt Ltd.)
- TDK Corporation
- Tuttnauer
- Biobase Biodusty(Shandong), Co., Ltd.
Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.